Home › Hydrocephalus › NCT06253858

Ultrasound (US) Guided External Ventricular Catheter Placement

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Decision made to perform the procedure by the primary consultant
* Age 18 or older
* Neuro ICU stay
* Newly diagnosed hydrocephalus
* Has a recent CT within the past 24 hrs
* Normal platelets and coagulation profile
* No active infection or currently on antibiotics
* The targeted fluid compartment has more than 50 percent CSF vs blood by CT scan imaging

Exclusion Criteria:

* Age \<18
* Not in Neuro ICU setting
* Previous placement of a ventricular catheter
* More than 50 percent of the fluid compartment is filled with blood by CT scan
* Time to include in the trial prohibited by clinical personnel

About the study

To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.

What is being tested

• Catheter Placement with Solopass System (device)

Sponsor: Milton S. Hershey Medical Center · Participants: 10 · Started: Apr 1, 2026

Contact the study team

• Sara Craig, MNR, BS · Phone: 717-531-0003

Official record on ClinicalTrials.gov — NCT06253858

Locations in the U.S.

Conditions

• Hydrocephalus

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.